StockData
Medicus Pharma Ltd. logo

Medicus Pharma Ltd. (MDCX) shareholders

MDCXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as MDCXW
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/30
$1.69−0.26 (-13.33%)

Close on Nov 16, 2026Market cap $3.13MP/E –Yield –

Ownership

Who owns Medicus Pharma's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Bokhari, Raza4,859,3495.30%13D (active)Sep 4, 2026
Ajay Raju
Joint filing with 215 Capital Togo PHL Fund I, LP (16.90%), Togo PHL Management LLC (16.90%)
2,000,00016.90%13G (passive)Dec 31, 2024
SkinJect Partners LLC
Joint filing with John Hathaway (6.80%)
800,9526.80%13G (passive)Dec 31, 2024

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares ownedLatest filing
Raza BokhariChief Executive Officer, Director3,734,349Sep 8, 2026
Andrew Alasdair SmithChief Operating Officer735,458Sep 8, 2026
Carolyn F. BonnerPresident and CFO1,489,493Sep 8, 2026
Edward J. BrennanChief Scientific Officer674,735Sep 8, 2026
Faisal MehmudChief Medical Officer1,470,588Sep 8, 2026
James P. QuinlanChief Financial Officer274,147Aug 14, 2025
Patrick J. MahaffyDirector35,435Jun 4, 2026
William AshtonDirector1,250Jun 4, 2026
Barry FishmanDirector–Jun 4, 2026
Ajay RajuDirector–Jun 4, 2026
Robert J. CiaruffoliDirector12,500Jun 4, 2026
Sara R. MayDirector–Jun 4, 2026
Larry KaiserDirector–Jun 4, 2026
Cathy McMorris RodgersDirector–Jun 4, 2026
Frank W. LavelleDirector25,622Jan 23, 2025
Velocity Fund Partners, Lp10% owner3,323,741May 21, 2025
Kenneth R. Melani10% owner3,658,152May 21, 2025
PHL Management LLC Togo10% owner–Dec 31, 2024
215 Capital TOGO PHL Fund I, LP10% owner2,000,000Dec 31, 2024

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Edward J. Brennan
Chief Scientific Officer
Sep 4, 2026Award+588,235$0.17$100.00K674,735
Raza Bokhari
Chief Executive Officer, Director
Sep 4, 2026Award+2,941,176$0.17$500.00K2,941,176
Andrew Alasdair Smith
Chief Operating Officer
Sep 4, 2026Award+735,294$0.17$125.00K735,458
Faisal Mehmud
Chief Medical Officer
Sep 4, 2026Award+1,470,588$0.17$250.00K1,470,588
Carolyn F. Bonner
President and CFO
Sep 4, 2026Award+1,470,588$0.17$250.00K1,489,493
James P. Quinlan
Chief Financial Officer
Aug 13, 2025Option exercise+20,000$2.75$55.00K274,147
James P. Quinlan
Chief Financial Officer
Aug 13, 2025Option exercise+125,000$0.81$101.25K254,147
Kenneth R. Melani
10% owner
May 20, 2025Sale−75,000$7.72$579.00K3,248,741

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
+42.2%
From 0M shares
Short volume, 20 days
44.3%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Medicus Pharma's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,263,145 shares on Oct 9, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Velocity Fund Partners, Lp
Major Shareholders
May 20, 2025118,000$23.07MMay 20, 2025Merger

See a number that looks wrong?